SCHEMBL6893951

SCHEMBL6893951

C=CCc1c(N=C)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 4/20 0.37
CYP2A6 P11509 2/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
IMPDH2 P12268 1/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 4/20 0.36
GAA P10253 3/20 0.36
MAPT P10636 3/20 0.36
TAAR1 Q96RJ0 1/20 0.36
HIF1A Q16665 2/20 0.36
CYP2D6 P10635 1/20 0.36
POLB P06746 1/20 0.35
HPRT1 P00492 1/20 0.34
GLA P06280 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7198503 0.79 TSHR (0.48) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL253635 0.77 HSD17B10 (0.41) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL31201820 0.75 HSD17B10 (0.63) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL2162162 0.75 IMPDH2 (0.61) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL28270200 0.75 HPGD (0.44) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL8637918 0.75 HSD17B10 (0.40) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL301407 0.75 HSD17B10 (0.40) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL1325658 0.75 HSD17B10 (0.63) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL2533977 0.75 HSD17B10 (0.40) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL7924281 0.75 HSD17B10 (0.40) HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235023-A1 Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof JACOBSEN ERIC N (US) 2004-11-25 US disclosed
US-6709824-B2 SCREENING SAMPLE FOR CATALYST; GENERATE LIBRARY OF CATALYST, SCREEN LIBRARY, RECOVER CATALYST PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2004-03-23 US disclosed
US-20020102612-A1 Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof JACOBSEN ERIC N (US) 2002-08-01 US disclosed
US-6316616-B1 USED AS CATALYST TO CATALYZE A CHEMOSELECTIVE, REGIOSELECTIVE, STEREOSELECTIVE OR ENANTIOSELECTIVE TRANSFORMATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2001-11-13 US disclosed
EP-1066228-A1 PARALLEL COMBINATORIAL APPROACH TO THE DISCOVERY AND OPTIMIZATION OF CATALYSTS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2001-01-10 EP disclosed
WO-1999051546-A9 PARALLEL COMBINATORIAL APPROACH TO THE DISCOVERY AND OPTIMIZATION OF CATALYSTS AND USES THEREOF HARVARD COLLEGE (US) 1999-11-18 WO disclosed
WO-1999051546-A1 PARALLEL COMBINATORIAL APPROACH TO THE DISCOVERY AND OPTIMIZATION OF CATALYSTS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020102612-A1 Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof COASY, DCXR, LSS HSD17B10 186/4885CYP1A2 94/4885CYP2C9 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.